The Zephirin Group, Inc. is widely recognized as a World Leading Independent Investment Research Company. The Wall Street Journal, Financial Times/StarMine and FactSet Research have recognized The Zephirin Group as an industry leader – naming us as one of the World's Top Analysts based on high performance and accuracy for earnings and stock picking. The Zephirin Group is a celebrated and award-winning Independent Investment Research Company and has been listed in the Top 5 Star Analyst List for all years 2008 to 2021 YTD. The firm offers equity research, fixed income research, corporate finance, quantitative research, and index research to financial services firms; business research, company profile, and industry studies to business services firms; and data analytics, index analytics, risk analytics, benchmark analytics, financial analysis, model development, and valuation modeling to data services firms. It offers research on small, mid and large capitalized under-valued and under-covered global-listed equities. The firm provides institutional research and sponsored research services. It offers pre-IPO services and reports, boutique services including merger and acquisition advisory, equity and debt raising advisory and energy and real estate advisory services. The firm offers fundamental research with a combination of top down and bottom up research. It also provides consulting on listing issues, compliance, corporate governance, and investor communication services. The Zephirin Group, Inc. is based in New York with satellite office in Hong Kong and Shenzhen.
BUSINESS ACCOUNT
Sign up for a business account to:
-
Access reports individually or via Subscription
-
Receive monthly invoices with payment via CSA or hard dollars
Get access to other exclusive features
-
Analyst access
-
Free Trial Subscriptions
-
Team account with shared subscriptions
-
Advanced analytics to track research consumption and performance
Lenny Zephirin
- Lenny Zephirin
Rapid Nutrition PLC (ALRPD.PA): Growth momentum – €1…!
>Trading Call. We are maintaining our BUY HIGH RISK recommendation on Rapid Nutrition PLC (ALRPD.PA) with a price objective of €1.00 per share. We continue to recommend accumulating the shares on any weakness. >Growth Momentum. Azurene and the SystemLS brand’s growth momentum in APAC aligns with rising demand for alternative wellness products. The brands have gained strong market traction and are poised for significant sales growth with robust margins by 2025. Continued product expansion and de...
Lenny Zephirin
- Lenny Zephirin
ALRPD.PA: Rebalance upward – €1…!
>Trading Call. We are maintaining our BUY on Rapid Nutrition PLC (ALRPD.PA), however, we are adjusting our risk rating to HIGH from SPECULATIVE. Our price objective of €1.00 per share is unchanged. Month-to-date, the shares are up by 68%, outperforming the peer group that is down by 2% and the Euronext 100 that is up by 1.9%, respectively. We recommend accumulate the shares on weakness. >Rebalance Upward. Following the termination of the second tranche of the Atlas convertible loan, the compa...
Lenny Zephirin
- Lenny Zephirin
ALRPD.PA: Brand value enhance - €1...!
Maintaining Investment Rating. We are reiterating our BUY SPECULATIVE RISK on Rapid Nutrition PLC (ALRPD.PA) and our price objective of €1.00 per share. Plant Based. 2024 is off to a good start as we are seeing the benefits of the acquisition the company did 2 years ago. The Plant-Based Bundle acquisition, which was acquired 2 years ago for approximately $500.0k, is a win-win for the company. The segment generated $976.8k in total revenue in 2023, equating to approximately 59.0% of total reve...
Lenny Zephirin
- Lenny Zephirin
JDE Peet’s N.V. (JDEP.AS) Momentum pick – BUY…!
Rating Changed. With this brief note, we are adjusting our investment rating to BUY MEDIUM RISK from SELL HIGH RISK on JDE Peet’s N.V. (JDEP.AS), and we are adjusting our price objective to €25 from €22/shr. YTD, the shares are down by approximately 22.0%, and we believe that the shares are attractive at their current level; thus, we recommend accumulating the shares despite the low float of 22.9%. Growing Consumption Rate. Worldwide, JDE Peet’s coffee is consumed at a rate of 4,100-4,500 cup...
Lenny Zephirin
- Lenny Zephirin
Rapid Nutrition PLC (ALRPD.PA): Recovery is underway…!
Investment Rating and Price Objective. Our investment thesis on Rapid Nutrition PLC (ALRPD.PA – BUY SPECULATIVE), remains unchanged. We continue to believe ALRPD.PA is among the best positioned within our coverage universe given the aggressive re-opening of global markets post-COVID and Generation Z's embrace of wellness and the vegan market, as well as via livestreaming. Inflection Point. 2023 should represent an inflection point as we continue to see a gradual improvement in ongoing strengt...
Lenny Zephirin
- Lenny Zephirin
Rapid Nutrition PLC (ALRPD.PA): Growth momentum – €1…!
>Trading Call. We are maintaining our BUY HIGH RISK recommendation on Rapid Nutrition PLC (ALRPD.PA) with a price objective of €1.00 per share. We continue to recommend accumulating the shares on any weakness. >Growth Momentum. Azurene and the SystemLS brand’s growth momentum in APAC aligns with rising demand for alternative wellness products. The brands have gained strong market traction and are poised for significant sales growth with robust margins by 2025. Continued product expansion and de...
Lenny Zephirin
- Lenny Zephirin
ALRPD.PA: Rebalance upward – €1…!
>Trading Call. We are maintaining our BUY on Rapid Nutrition PLC (ALRPD.PA), however, we are adjusting our risk rating to HIGH from SPECULATIVE. Our price objective of €1.00 per share is unchanged. Month-to-date, the shares are up by 68%, outperforming the peer group that is down by 2% and the Euronext 100 that is up by 1.9%, respectively. We recommend accumulate the shares on weakness. >Rebalance Upward. Following the termination of the second tranche of the Atlas convertible loan, the compa...
Lenny Zephirin
- Lenny Zephirin
ALRPD.PA: Brand value enhance - €1...!
Maintaining Investment Rating. We are reiterating our BUY SPECULATIVE RISK on Rapid Nutrition PLC (ALRPD.PA) and our price objective of €1.00 per share. Plant Based. 2024 is off to a good start as we are seeing the benefits of the acquisition the company did 2 years ago. The Plant-Based Bundle acquisition, which was acquired 2 years ago for approximately $500.0k, is a win-win for the company. The segment generated $976.8k in total revenue in 2023, equating to approximately 59.0% of total reve...
Lenny Zephirin
- Lenny Zephirin
JDE Peet’s N.V. (JDEP.AS) Momentum pick – BUY…!
Rating Changed. With this brief note, we are adjusting our investment rating to BUY MEDIUM RISK from SELL HIGH RISK on JDE Peet’s N.V. (JDEP.AS), and we are adjusting our price objective to €25 from €22/shr. YTD, the shares are down by approximately 22.0%, and we believe that the shares are attractive at their current level; thus, we recommend accumulating the shares despite the low float of 22.9%. Growing Consumption Rate. Worldwide, JDE Peet’s coffee is consumed at a rate of 4,100-4,500 cup...
Lenny Zephirin
- Lenny Zephirin
Rapid Nutrition PLC (ALRPD.PA): Recovery is underway…!
Investment Rating and Price Objective. Our investment thesis on Rapid Nutrition PLC (ALRPD.PA – BUY SPECULATIVE), remains unchanged. We continue to believe ALRPD.PA is among the best positioned within our coverage universe given the aggressive re-opening of global markets post-COVID and Generation Z's embrace of wellness and the vegan market, as well as via livestreaming. Inflection Point. 2023 should represent an inflection point as we continue to see a gradual improvement in ongoing strengt...
Lenny Zephirin
- Lenny Zephirin
Oil & Gas: OPEC, Market is Wrong...!
Hiccup. While OPEC members have gone through several hiccups the past 43-years, however, total oil production is up by 10.3% from 1974. Ex-Iraq, oil production is up only by 2% from 1974. OPEC market share currently stands at an estimated 36% in July vs. 43% in 2016 and 51% in 1974. OPEC historical low market share was 27.6% in 1985.